Distinct immune profiles characterize patients with diffuse or limited systemic sclerosis.

Area of Science:

• Immunology
• Rheumatology
• Cell Biology

Background:

• Systemic sclerosis (SSc) is an autoimmune disease characterized by immune system dysregulation.
• Understanding cytokine profiles and immune cell phenotypes is crucial for SSc pathogenesis.

Purpose of the Study:

• To investigate cytokine production (IL-2, IFN-gamma, TNF-alpha, IL-10) and immune cell surface marker expression in SSc patients.
• To compare immune profiles between diffuse (dSSc) and limited (lSSc) SSc subtypes and healthy controls (HCs).
• To evaluate the impact of treatments like prednisone and cyclophosphamide on these immune parameters.

Main Methods:

• Peripheral blood mononuclear cells (PBMCs) from 54 SSc patients and 20 HCs were analyzed.
• Cytokine production (IL-2, IFN-gamma, TNF-alpha, IL-10) was measured.
• Expression of immune cell surface markers (e.g., CD4, CD8, CD25, CD45RA, CD28, CD57, CD95) was assessed.

Main Results:

• Untreated SSc patients showed reduced IL-2 and elevated IL-10 compared to HCs.
• lSSc patients had higher IL-10, IFN-gamma, and TNF-alpha production than dSSc patients.
• Reduced CD4+25+, CD8+, and memory CD8+ lymphocytes were observed in SSc patients.
• CD95 expression was higher on CD4+ and CD8+ cells in dSSc.
• Prednisone alone was more effective than combined therapy in reducing IL-10 and IFN-gamma.

Conclusions:

• SSc patients exhibit a significant imbalance in type 1 and type 2 cytokine production.
• Specific immune cell populations, including regulatory T cells and memory T cells, are underrepresented in SSc.
• Overexpression of Fas (CD95) in dSSc may reflect an attempt to eliminate autoreactive T cells.